Biocon 400mg Krabeva Bevacizumab Injection

Get a Price/Quote

Biocon 400mg Krabeva Bevacizumab Injection Specification

Pacakaging (Quantity Per Box)
1 vial per box

Salt Composition
Bevacizumab 400 mg

Packaging Type
Single-use vial

Indication
Indicated for use in the treatment of various cancers based on clinical evaluation

Life Span
Refer to expiration date on the packaging

Dosage Form
Intravenous infusion liquid solution

Brand Name
Krabeva

Origin of Medicine
India (Manufactured by Biocon)

Drug Type
Anti-cancer monoclonal antibody

Ingredients
Bevacizumab (r-DNA Origin)

Physical Form
Injection (liquid solution)

Function
Anti-cancer, used in targeted cancer therapy

Recommended For
Patients prescribed Bevacizumab for cancer therapy as per physician guidance

Dosage
400 mg per vial

Dosage Guidelines
Administer as intravenous infusion under medical supervision

Suitable For
Adults (as per physicians advice)

Quantity
16 mL per vial (Concentrate)

Storage Instructions
Store at 2C to 8C. Do not freeze. Protect from light.

Strength
400 mg per 16 mL

Molecule Category
r-DNA Origin Monoclonal Antibody

Prescription/Non-prescription
Prescription drug

Use
Concentrate for solution preparation for intravenous infusion

Manufactured By
Biocon Limited

Route of Administration
Intravenous (IV) infusion only

Therapeutic Class
Oncology

Vial Type
Single-use glass vial

Appearance
Clear to slightly opalescent, colorless to pale brownish-yellow solution

Registration Category
Rx / Prescription only

About Biocon 400mg Krabeva Bevacizumab Injection

Put your health in the spotlight with the monumental Biocon 400mg Krabeva Bevacizumab Injection-a top-notch anti-cancer remedy now available on promotion. Engineered by Biocon Limited, this sublime prescription product belongs to the r-DNA origin monoclonal antibody class, designed for targeted oncology treatment. Each single-use glass vial delivers 400 mg of Bevacizumab in a clear to slightly opalescent solution, suitable strictly for intravenous infusion under clinical supervision. Krabeva is your trusted support for precise cancer therapy-harnessing Biocon's renowned standards and quality to maximize patient outcomes.

Versatile Oncology Solution for Advanced Care

Biocon 400mg Krabeva Bevacizumab Injection is primarily used as a potent anti-cancer agent in targeted cancer therapies. Beyond its monumental role in treating various cancers, it is also leveraged in hospital oncology wards and specialized cancer clinics for adult patients as prescribed by physicians. Its usage extends to addressing conditions as determined through clinical evaluation, ensuring each patient receives sublime, tailored therapy with trusted efficacy.

Reliable Supply and Global Distribution Assurance

Our stock-ready inventory ensures prompt delivery times, catering to both domestic and international markets at the lowest price. Products are shipped securely, maintaining the integrity of each single-use vial. Biocon 400mg Krabeva Bevacizumab Injection meets top-tier certifications, aligning with stringent pharmaceutical standards for export to major markets. Shipped goods are always accompanied by relevant documentation, assuring authenticity and quality for our valued retailers and suppliers worldwide.

FAQ's of Biocon 400mg Krabeva Bevacizumab Injection:

Q: How should Biocon 400mg Krabeva Bevacizumab Injection be administered?

A: Biocon Krabeva 400mg should be administered only as an intravenous infusion, prepared as a solution under the supervision of medical professionals following precise dosage guidelines set by a physician.

Q: What is the primary use of Krabeva Bevacizumab Injection?

A: Krabeva Bevacizumab Injection is indicated for targeted cancer therapy in adults. It is used for treating various cancers, based on thorough clinical evaluation and direction by a healthcare provider.

Q: When can patients expect delivery of their order?

A: We maintain a stock-ready system, enabling expedited shipment. Customers can usually expect their goods to be shipped promptly after order confirmation, ensuring fast delivery to all main export markets.

Q: Where is Biocon 400mg Krabeva manufactured and supplied from?

A: Krabeva 400mg is manufactured in India by Biocon Limited and is available for supply domestically and internationally, reaching a wide range of hospitals, clinics, retailers, and suppliers.

Q: What are the storage and handling requirements for this injection?

A: Krabeva Bevacizumab vials must be stored at temperatures between 2C and 8C. Do not freeze the vials and always protect them from exposure to light to preserve product quality.

Tell us about your requirement